American National Bank & Trust (Virginia)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$578K Buy
+7,896
New +$607K 0.14% 96
2015
Q4
$2.95M Sell
29,156
-1,281
-4% -$133K 1.41% 25
2015
Q3
$2.99M Sell
30,437
-904
-3% -$100K 1.52% 20
2015
Q2
$3.67M Sell
31,341
-3,489
-10% -$381K 1.74% 13
2015
Q1
$3.42M Sell
34,830
-4,972
-12% -$505K 1.61% 20
2014
Q4
$3.75M Sell
39,802
-3,714
-9% -$384K 1.79% 13
2014
Q3
$4.63M Sell
43,516
-4,597
-10% -$450K 2.26% 6
2014
Q2
$3.99M Sell
48,113
-8,118
-14% -$632K 2.02% 11
2014
Q1
$3.98M Sell
56,231
-25,457
-31% -$2M 2.04% 13
2013
Q4
$6.13M Sell
81,688
-3,183
-4% -$222K 3.1% 5
2013
Q3
$5.33M Sell
84,871
-1,668
-2% -$99.7K 2.88% 6
2013
Q2
$4.44M Buy
+86,539
New +$4.51M 2.46% 11

Other funds holding GILD

American National Bank & Trust (Virginia)'s GILD Position: Q1 2024 in Review

American National Bank & Trust (Virginia) opened a new position in Gilead Sciences (GILD) in Q1 2024: 7,896 shares worth $578K. The stake represents 0.14% of the portfolio and ranks #96 among its holdings. This is a return to the name: American National Bank & Trust (Virginia) previously reported a position in GILD as recently as Q4 2015.

American National Bank & Trust (Virginia) first reported a position in GILD in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.13M in Q4 2013. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • American National Bank & Trust (Virginia) held 7,896 shares of Gilead Sciences worth $578K as of Q1 2024.
  • Gilead Sciences was a new American National Bank & Trust (Virginia) position in Q1 2024.
  • Gilead Sciences made up 0.14% of American National Bank & Trust (Virginia)'s portfolio in Q1 2024, its #96 holding.
  • American National Bank & Trust (Virginia) first reported a position in Gilead Sciences in Q2 2013 and has held it in 12 quarters since.
  • American National Bank & Trust (Virginia)'s Gilead Sciences position peaked at $6.13M in Q4 2013.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on American National Bank & Trust (Virginia)'s 13F filing for Q1 2024, filed 19 Apr 2024.